ARCHIVES

White House appoints NCI Director Andrew von Eschenbach acting FDA commissioner after Lester Crawford resigns.

This article is from The Cancer Letter archive.

Vol. 31 No. 35 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

Fox Chase Publishes Its Cancer Survival Data

February 4, 2011

NCAB Considering Concept Review Of Large, Expensive Investigator Initiated Proposals

February 16, 1990

NCI Director Klausner Resigns To Head Institute Begun By AOL Chairman Case.

September 14, 2001

Combine Phase 1-2, Abolish DRG, Slash Indirect Costs, Garb Tells Congress

November 27, 1981

NS Sponsors Workshop On Prevention For Three Minority Groups

July 1, 1988

Book Offers Info For Women Considering Ovary Removal

November 24, 2006